A second reason is the unsubstantiated and hypothetical concern that CC, by virtue of its intended increase in LH, might inadvertently result in a false-positive elevation in the testicular cancer tumor marker, beta-human chorionic gonadotrophin (beta-HCG). The gene discussed is PLOD1; the disease is neoplasm.